Showing results (1271-1280 of 1,685) with videos related to

Sort By:
Pageof 169
Communications Biology|August 15, 2025
Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's diseaseClaire O'Callaghan, Frank H Hezemans, Naresh Subramaniam, et al.
Nature Neuroscience|November 11, 2014
Molecular and functional definition of the developing human striatumMarco Onorati, Valentina Castiglioni, Daniele Biasci, et al.
Parkinsonism & Related Disorders|May 21, 2019
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionNaveed Malek, Sofia Kanavou, Michael A Lawton, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Plant Biotechnology Journal|January 3, 2013
Discovery and development of exome-based, co-dominant single nucleotide polymorphism markers in hexaploid wheat (Triticum aestivum L.)Alexandra M Allen, Gary L A Barker, Paul Wilkinson, et al.
Diabetes, Obesity & Metabolism|October 15, 2013
Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal studyA Barker, A Lauria, N Schloot, et al.
European Journal of Endocrinology|November 8, 2014
BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old childrenA Lauria, A Barker, N Schloot, et al.
The Journal of Biological Chemistry|February 13, 2014
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cellsPeter A Forsyth, Niveditha Krishna, Samuel Lawn, et al.
The Pharmacogenomics Journal|February 15, 2020
Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practicePrathima Anandi, Alyson L Dickson, QiPing Feng, et al.
Journal of Neurology|March 6, 2025
Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severityMelanie Alpaugh, Juan Lantero-Rodriguez, Andrea L Benedet, et al.
Pageof 169